AIM ImmunoTech to Participate in Virtual Investor CEO Connect Segment

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

Live video webcast with Tom Equels, Chief Executive Officer of AIM ImmunoTech, on Wednesday, October 2nd at 4:00 PM ET

OCALA, Fla., Sept. 27, 2024 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that Thomas K. Equels, Chief Executive Officer of AIM will participate in a Virtual Investor CEO Connect segment on Wednesday, October 2, 2024 at 4:00 PM ET.

As part of the event, Mr. Equels will provide a brief presentation, followed by an interactive Q&A session. Investors and interested parties will have the opportunity to submit questions live during the event. Questions can also be pre-submitted leading up to the event by emailing AIM@jtcir.com. Mr. Equels will answer as many questions as possible in the time allowed.

A live video webcast of the presentation will be available on the Events page of the Company’s website (aimimmuno.com). A webcast replay will be available two hours following the live presentation and will be accessible for 90 days.

About AIM ImmunoTech Inc.

AIM ImmunoTech Inc. is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders and viral diseases, including COVID-19. The Company’s lead product is a first-in-class investigational drug called Ampligen® (rintatolimod), a dsRNA and highly selective TLR3 agonist immuno-modulator with broad spectrum activity in clinical trials for globally important cancers, viral diseases and disorders of the immune system.

For more information, please visit aimimmuno.com and connect with the Company on XLinkedIn, and Facebook.

CONTACT: Investor Contact:

JTC Team, LLC
Jenene Thomas
908.824.0775
AIM@jtcir.com

Staff

Recent Posts

Beyond Medical Technologies Announces Private Placement to Advance Blockchain Infrastructure

Vancouver, British Columbia--(Newsfile Corp. - April 1, 2025) - Beyond Medical Technologies Inc. (CSE: DOCT)…

13 minutes ago

TE Connectivity completes acquisition of Richards Manufacturing

GALWAY, Ireland, April 1, 2025 /PRNewswire/ -- TE Connectivity plc (NYSE: TEL), a world leader…

2 hours ago

Koning Health Announces Expansion of Vera Scan Installations Across the United States

NORCROSS, Ga., April 1, 2025 /PRNewswire/ -- Koning Health proudly announces its continued nationwide expansion,…

2 hours ago

Resolution Medical Billing Announces Acquisition of Claims Express LLC

Resolution Medical Billing  looks forward to working with Claims Express Clients current clients and envisions…

2 hours ago

Community Dental Care, Inc. Provides Notice Following Data Security Incident

MAPLEWOOD, Minn., April 1, 2025 /PRNewswire/ -- Community Dental Care, Inc. ("CDC"), a Minnesota based…

2 hours ago